- The Supreme Court of India emphasized the need to cap trade margins for all essential medicines and medical products to prevent exorbitant pricing and profiteering. - High out-of-pocket healthcare expenditure driven by high drug and medical device costs remains a major concern for patients and public health systems. - The ruling highlights the judicial push to ensure affordable access to healthcare, empowering regulatory frameworks like the National Pharmaceutical Pricing Authority (NPPA). - **Drugs (Prices Control) Order (DPCO):** An order issued by the central government under the Essential Commodities Act to regulate the prices of scheduled formulations and medical devices to ensure affordability and public accessibility. - **National Pharmaceutical Pricing Authority (NPPA):** A government regulatory body responsible for fixing and revising prices of scheduled drugs and implementing provisions of the Drugs (Prices Control) Order. - **Supreme Court:** The apex judicial body in India that interprets the Constitution, protects fundamental rights like the Right to Health, and ensures executive accountability in policy matters. **Introduction** The Supreme Court has called for a cap on trade margins for all essential medicines and medical products, aiming to curb predatory pricing and make healthcare more accessible and affordable by reducing out-of-pocket expenditure. **Core Issue and Detailed Points** - The Supreme Court of India emphasized the need to cap trade margins for all essential medicines and medical products to prevent exorbitant pricing and profiteering. - High out-of-pocket healthcare expenditure driven by high drug and medical device costs remains a major concern for patients and public health systems. - The ruling highlights the judicial push to ensure affordable access to healthcare, empowering regulatory frameworks like the National Pharmaceutical Pricing Authority (NPPA). **Key Statutory Bodies, Acts & Concepts** - **Drugs (Prices Control) Order (DPCO):** An order issued by the central government under the Essential Commodities Act to regulate the prices of scheduled formulations and medical devices to ensure affordability and public accessibility. - **National Pharmaceutical Pricing Authority (NPPA):** A government regulatory body responsible for fixing and revising prices of scheduled drugs and implementing provisions of the Drugs (Prices Control) Order. - **Supreme Court:** The apex judicial body in India that interprets the Constitution, protects fundamental rights like the Right to Health, and ensures executive accountability in policy matters.